Vaxcyte, Inc. (PCVX) Misses Q4 EPS by 77c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q4 EPS of ($1.82), $0.77 worse than the analyst estimate of ($1.05).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Adobe (ADBE) PT Raised to $250 at Baird
• Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance